Lataa...
A retrospective study of docetaxel and bevacizumab as a second- or later-line chemotherapy for non-small cell lung cancer
Comparative results of second- or later-line bevacizumab plus docetaxel and docetaxel alone for patients with NSCLC have never been reported. In order to evaluate the combined effect of bevacizumab and docetaxel as second- or later-line chemotherapy for NSCLC, a retrospective study was performed. Be...
Tallennettuna:
| Julkaisussa: | Mol Clin Oncol |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
D.A. Spandidos
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5492640/ https://ncbi.nlm.nih.gov/pubmed/28685090 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2017.1282 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|